IMMUPHARMA PLC
IMMUPHARMA PLC
Share · GB0033711010 · A0BMC4 (XLON)
Overview Financial Indicators
0,03 GBP
-1,31 % -0,0003 GBP
Closing Price XLON 06.06.2025: 2,64 GBX
London (XLON) · Current prices and charts at MoneyPeak
06.06.2025 15:04

Current Prices from IMMUPHARMA PLC

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
IMM.L
GBX
06.06.2025 15:04
2,64 GBX
2,53 GBX
+4,35 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -0,56 % -13,16 % -19,57 % 120,00 % 8,64 % -82,52 %

Company Profile for IMMUPHARMA PLC Share

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.

Company Data

Name IMMUPHARMA PLC
Company ImmuPharma plc
Website https://www.immupharma.co.uk
Primary Exchange XLON London
WKN A0BMC4
ISIN GB0033711010
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Timothy Paul McCarthy XIV, FCCA, M.B.A., MBA
Market Capitalization 13 Mio
Country United Kingdom
Currency GBP
Employees 0,0 T
Address 1 Bartholomew Close, EC1A 7BL London
IPO Date 2003-10-28
Dividends from 'IMMUPHARMA PLC '
Ex-Date Dividend per Share
14.12.2021 1,00 GBX

Ticker Symbols

Name Symbol
Frankfurt 25I.F
London IMM.L

More Shares

Investors who IMMUPHARMA PLC hold also have the following shares in their portfolio:
LB.HESS.THR.CARRARA02Y/19
LB.HESS.THR.CARRARA02Y/19 Bond
SWEDEN 15-26 1059
SWEDEN 15-26 1059 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025